|
CCDC52 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.68589999999647E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.758300E-03 |
| Normal-vs-Stage2 |
3.134100E-02 |
| Normal-vs-Stage3 |
6.499500E-02 |
| Normal-vs-Stage4 |
8.922400E-01 |
| Stage1-vs-Stage2 |
3.954800E-01 |
| Stage1-vs-Stage3 |
7.434000E-01 |
| Stage1-vs-Stage4 |
2.336200E-01 |
| Stage2-vs-Stage3 |
3.260200E-01 |
| Stage2-vs-Stage4 |
1.338440E-01 |
| Stage3-vs-Stage4 |
2.670000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.58250000000293E-05 |
| Normal-vs-AfricanAmerican |
6.663500E-03 |
| Normal-vs-Asian |
5.131800E-01 |
| Caucasian-vs-AfricanAmerican |
5.402600E-01 |
| Caucasian-vs-Asian |
4.348400E-01 |
| AfricanAmerican-vs-Asian |
5.050000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.409700E-04 |
| Normal-vs-Female |
2.249100E-04 |
| Male-vs-Female |
3.175200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.188800E-01 |
| Normal-vs-Extreme_Weight |
1.763720E-02 |
| Normal-vs-Obese |
8.411300E-04 |
| Normal-vs-Extreme_Obese |
2.624200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.861800E-01 |
| Normal_Weight-vs-Obese |
4.687800E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.032800E-01 |
| Extreme_Weight-vs-Obese |
2.993000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.702200E-01 |
| Obese-vs-Extreme_Obese |
8.251400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.257600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.94593999999215E-05 |
| Normal-vs-Age(61-80Yrs) |
2.320300E-03 |
| Normal-vs-Age(81-100Yrs) |
6.214800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.586200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.934000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.349700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.818390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.679200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.445800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.3533000004814E-07 |
| Normal-VS-Type2 PRCC |
8.184000E-01 |
| Normal-VS-KIRP CIMP |
2.535800E-01 |
| Normal-VS-Unclassified PRCC |
5.718000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.34789999559371E-08 |
| Type1 PRCC-VS-KIRP CIMP |
2.148200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.729600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.382800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.955800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.348200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.047000E-01 |
| Normal-vs-N1 |
3.496200E-02 |
| Normal-vs-N2 |
9.045400E-01 |
| N0-vs-N1 |
1.368400E-01 |
| N0-vs-N2 |
6.727600E-01 |
| N1-vs-N2 |
3.828800E-01 |
|
|
